Skip to main content Back to Top
Advertisement

5/30/2019

Diltiazem Extended-Release Capsules (Twice-Daily Dosing)

Products Affected - Description

    • Diltiazem Hydrochloride oral extended release capsule, Mylan Institutional, 90 mg, unit-dose blister pack, 100 count, NDC 51079-0925-20

Reason for the Shortage

    • Mylan did not provide a reason for the shortage.

Available Products

    • Diltiazem Hydrochloride oral extended release capsule, Mylan, 120 mg, bottle, 100 count, NDC 00378-6120-01
    • Diltiazem Hydrochloride oral extended release capsule, Mylan, 60 mg, bottle, 100 count, NDC 00378-6060-01
    • Diltiazem Hydrochloride oral extended release capsule, Mylan, 90 mg, bottle, 100 count, NDC 00378-6090-01
    • Diltiazem Hydrochloride oral extended release capsule, Mylan Institutional, 120 mg, unit-dose blister pack, 100 count, NDC 51079-0926-20
    • Diltiazem Hydrochloride oral extended release capsule, Mylan Institutional, 60 mg, unit-dose blister pack, 100 count, NDC 51079-0924-20

Estimated Resupply Dates

    • Mylan Institutional refuses to provide availability information.

Updated

Updated May 30, 2019 by Michelle Wheeler, PharmD, Drug Information Specialist. Created November 28, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins